top of page

Pharma and Life Science Services

S-3 offers data science services for a number of use cases in the pharmaceutical and life sciences sector.  Services are customizable to different data sources, research methods, and specific deliverables

All of these engagements allow modular service delivery that can generate novel intelligence and insights into supply chain security, clinical trial recruitment, barriers and facilitators to treatment, and brand awareness and protection

Image by Christina Victoria Craft

Detection of Illicit Pharmaceutical Sellers Online

Whether it be an illegal online pharmacy, a dark web seller, social media distributor, counterfeit purveyor, or an online pharmacy affiliate network, S-3's comprehensive multi-platform tools can find illegal selling of your product online and effectuate enforcement actions


Our online product monitoring services will help protect brand holders against grey market sellers that represent a threat to brand integrity, revenue, your intellectual property rights, and can compromise patient safety

Heat map of COVID-19 trials located in the United States

Helping Young Adult Minorities Enroll in Clinical Trials

Through a cooperative agreement awarded by the U.S. Food and Drug Administration, S-3 is generating novel intelligence and digital tools to identify barriers and facilitators for clinical trial participation for COVID-19 


Our RaaS offerings for clinical research participation include GIS services for clinical trials data (e.g.,, multi-platform social listening, qualitative focus groups, and digital tool co-ideation and testing 

Learn More

Multi-platform Social Listening to Identify Barriers to Treatment Access

S-3 has led several research projects using social listening, big data, and machine learning to identify barriers to treatment access for different therapeutic areas and public health challenges


Our published research and service offerings include prior work characterizing beliefs, attitudes, and behaviors associated with HIV prevention treatment (PrEP), COVID-19 treatments and vaccines, substance use disorder, and tobacco and vaping use to name a few 

Learn More

Analysis of CMS Open Payments data by S-3 Research co-authors

Analysis of HCP and Health Marketing Data

From big data, statistical, and geospatial analysis of CMS Open Payments data to comprehensive multi-platform analysis of direct-to-consumer-advertising, S-3 has expertise in understanding the media and marketing landscape for HCP and health product promotion


Our RaaS services include brand monitoring and awareness, sentiment analysis, statistical analysis of healthcare spending and marketing data, and GIS services to identify hot and cold spots for marketing and health promotion from a combination of data sources

Learn More

Learn more about our RaaS Offerings

Fill in the below information to reach out to us and schedule a consultation/demo

Thanks for submitting!
bottom of page